Patients with bronchiectasis have symptoms of persistent cough and excess sputum production as a result of permanently damaged airways. Respiratory physiotherapy, in particular airway clearance techniques (ACTs), form the cornerstone in the management of bronchiectasis. However, there is a lack of valid and reliable clinimetric outcome measures to evaluate the effectiveness of various ACTs. This study aims to examine the feasibility of electrical impedance tomography in assessing the short-term effects of airway clearance in patients with bronchiectasis.
- Category
-
Trial status
Not yet recruiting
-
Trial phase
OtherOther
- Registry listing
-
ERM Project ID
HREC/MML/103953 (V2)
Trial contact details
-
Contact person
Judy Hough
-
Phone
0422 404 369
What you need to know
Inclusion criteria
- Has a diagnosis of bronchiectasis
- Productive of secretions that require routine airway clearance
- Performs ACTs regularly at home
- Willing and able to provide informed consent
Exclusion criteria
- Contraindicated for ACTs, including chest trauma, facial trauma or facial burns, bleeding disorder, uncontrolled bronchospasm, and current haemoptysis.
- Contraindicated for EIT measurements, including pacemaker, automatic implantable cardioverter defibrillator, and implantable pumps.
- Inability to follow instructions.
- Patients less than 18 years of age.
Trial Dates
1 March to 1 October 2024